Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Mustanski

Showing results (381-390 of 403) with videos related to

Pageof 41
Sort By:
Open Forum Infectious Diseases|July 28, 2021
Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive AdultsJoshua M Schrock, Daniel T Ryan, Rana Saber, et al.
JMIR Research Protocols|May 18, 2026
Evaluating a Multimedia Messaging Intervention to Increase Adolescent HIV Testing: Protocol for a Hybrid Type 1 Effectiveness Implementation StudyKathryn Macapagal, Andrés Alvarado Avila, Zach M Buehler, et al.
The Journal of Infectious Diseases|June 12, 2021
COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to MenAlexis R Demonbreun, Amelia Sancilio, Matt E Velez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adultsJoshua M Schrock, Daniel T Ryan, Rana Saber, et al.
AIDS and Behavior|August 18, 2025
Comparing Implementation and Effectiveness Outcomes for Two Implementation Strategies of the Keep It Up! Digital HIV Prevention Program: A Type 3 Hybrid Effectiveness-Implementation TrialBrian Mustanski, Nanette Benbow, Kathryn Macapagal, et al.
Scientific Reports|July 19, 2022
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological studyAmelia Sancilio, Joshua M Schrock, Alexis R Demonbreun, et al.
Drug and Alcohol Dependence|September 19, 2022
Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIVPamina M Gorbach, Alison D Rosen, Richard Moore, et al.
Trials|June 20, 2022
Protocol for an attention-matched randomized controlled trial of 2GETHER: a relationship education and HIV prevention program for young male couplesMichael E Newcomb, Elissa L Sarno, Emily Bettin, et al.
Preventive Medicine Reports|July 17, 2023
Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO consortiumMarjan Javanbakht, Lamia Khan, Brian Mustanski, et al.
Drug and Alcohol Dependence|September 28, 2022
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and CanadaSoroush Moallef, Becky L Genberg, Kanna Hayashi, et al.
Pageof 41

Showing results (381-390 of 403) with videos related to

Sort By:
Pageof 41
Open Forum Infectious Diseases|July 28, 2021
Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive AdultsJoshua M Schrock, Daniel T Ryan, Rana Saber, et al.
JMIR Research Protocols|May 18, 2026
Evaluating a Multimedia Messaging Intervention to Increase Adolescent HIV Testing: Protocol for a Hybrid Type 1 Effectiveness Implementation StudyKathryn Macapagal, Andrés Alvarado Avila, Zach M Buehler, et al.
The Journal of Infectious Diseases|June 12, 2021
COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to MenAlexis R Demonbreun, Amelia Sancilio, Matt E Velez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adultsJoshua M Schrock, Daniel T Ryan, Rana Saber, et al.
AIDS and Behavior|August 18, 2025
Comparing Implementation and Effectiveness Outcomes for Two Implementation Strategies of the Keep It Up! Digital HIV Prevention Program: A Type 3 Hybrid Effectiveness-Implementation TrialBrian Mustanski, Nanette Benbow, Kathryn Macapagal, et al.
Scientific Reports|July 19, 2022
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological studyAmelia Sancilio, Joshua M Schrock, Alexis R Demonbreun, et al.
Drug and Alcohol Dependence|September 19, 2022
Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIVPamina M Gorbach, Alison D Rosen, Richard Moore, et al.
Trials|June 20, 2022
Protocol for an attention-matched randomized controlled trial of 2GETHER: a relationship education and HIV prevention program for young male couplesMichael E Newcomb, Elissa L Sarno, Emily Bettin, et al.
Preventive Medicine Reports|July 17, 2023
Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO consortiumMarjan Javanbakht, Lamia Khan, Brian Mustanski, et al.
Drug and Alcohol Dependence|September 28, 2022
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and CanadaSoroush Moallef, Becky L Genberg, Kanna Hayashi, et al.
Pageof 41